Compuware Partners IBM

Zacks

Compuware Corp. (CPWR) recently announced that it has collaborated with International Business Machines Corp (IBM) in order to help its customers to access the advanced analytics solutions from IBM.

Compuware’s Changepoint, which provides Professional Services Automation (“PSA”) and Project Portfolio Management (“PPM”) solutions, will now leverage IBM’s business analytics solutions to manage large number of data (big data) and sort them to provide insightful and relevant business data. This data will likely aid business growth and facilitate enhanced decision making.

Moreover, the integration of both the solutions are expected to benefit clients, thereby providing them with financial forecasting, operational efficiency and resource planning, thus improving the service altogether.

The collaboration is expected to be beneficial for both the companies in attracting new clients and expanding the addressable market, particularly for IBM, which expects its analytics business to grow to $16 billion 2015.

According to research firm Gartner’s survey, majority of the technology companies have invested in big data projects that primarily deal with revenue projections and new business opportunities by sorting random data sets.

Recommendation

We believe that IBM, a Zacks Rank #3 (Hold) stock, has a vast product portfolio that will boost its market share going forward. Moreover, with strong balance sheet and incremental revenues, the company’s strategic acquisitions and partnerships will have a positive impact in the long run.

However, competition from EMC Corp (EMC) and Oracle (ORCL) in the big data segment is a near-term headwind for the company.

Compuware, a Zacks Rank #2 (Buy) stock, has strong portfolio of products comprising mainframe software, project-management tools collaboration technology and performance-management services for cloud computing and mobile applications. Moreover, new program wins and introduction of new products are expected to benefit the company going forward.

Read the Full Research Report on IBM

Read the Full Research Report on EMC

Read the Full Research Report on CPWR

Read the Full Research Report on ORCL

Zacks Investment Research



More From Zacks.com

Rates

View Comments (0)